Results 161 to 170 of about 279,988 (315)

Microcontroller based artificial synapse

open access: yes, 2005
This paper discusses a novel artificial synapse implementation utilizing a PIC microcontroller. This artificial synapse controls a post-synaptic neuron based upon the frequency of pulses input from a pre-synaptic neuron.
Sun, Ying   +3 more
core  

Genome‐Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma

open access: yesAdvanced Science, EarlyView.
A genome‐wide microRNA CRISPR screen identifies miR‐18a as a master regulator of cross‐resistance in melanoma. Loss of miR‐18a activates the AJUBA–YAP/Hippo axis to confer BRAFi resistance and enhances THBS1–CD47 interaction to impair CD8+ T cell immunity. hnRNP A1 is identified as an upstream regulator of miR‐18a processing.
Zhao Wang   +19 more
wiley   +1 more source

Synapse

open access: yes, 2001
This is the Winter, 2001 edition of the ALHeLa newsletter - Synapse. Contents include: ALHeLA Executive Committee Members (2001) Executive Committee Meeting January 19 ...
Libraries Association, Alabama Health
core  

Functional Analysis of Ligand‐Gated Chloride Channels in a Cnidarian Sheds Light on the Evolution of Inhibitory Signaling

open access: yesAdvanced Science, EarlyView.
We uncover a large variety of putative inhibitory ligand‐gated ion channels (LGICs) in the phylum Cnidaria, the sister group to all bilaterian animals. Phylogenetic analysis suggests a complex evolutionary history of inhibitory LGICs with diverse neurotransmitter ligands.
Abhilasha Ojha   +13 more
wiley   +1 more source

Fibronectin1‐Expressing Subicular Circuits Selectively Govern the Retrieval of Novel Object Recognition

open access: yesAdvanced Science, EarlyView.
Fibronectin 1 (FN1)‐expressing subicular subpopulations encode novel object preference and selectively govern retrieval of novel object recognition (NOR) via affecting excitability of entorhinal‐projecting circuit through large conductance Ca2+‐activated potassium (BK) channel. ABSTRACT Novel object recognition (NOR), referring to the cognitive ability
Fan Fei   +15 more
wiley   +1 more source

Targeting the PDK1/c‐Myc/SOX10 Signaling in Oligodendrocytes Alleviates Neuropathic Pain

open access: yesAdvanced Science, EarlyView.
This work reveals that oligodendrocyte homeostasis, mediated by PDK1, is a critical determinant of neuropathic pain (NPP) pathogenesis. Disruption of PDK1 in oligodendrocytes impairs SOX10‐dependent myelination programs through c‐Myc accumulation, leading to disrupted myelination and the pathophysiology of NPP.
Pingping Qiao   +7 more
wiley   +1 more source

Synapse

open access: yes, 2004
This is the Winter, 2004 edition of the ALHeLa newsletter - Synapse. Contents include: Tracy Powell Recognized ALHeLA Executive Committee 2004 ALHeLA Executive Committee ...
Libraries Association, Alabama Health
core  

Enhanced Glycolysis‐Driven Histone H3K18 Lactylation Regulates Epileptogenesis by Modulating the E3 Ubiquitin Ligase COP1

open access: yesAdvanced Science, EarlyView.
Neuronal PKM2‐driven glycolysis generates excess lactate that triggers histone H3K18 lactylation (H3K18la), establishing a pathogenic metabolic‐epigenetic axis in epilepsy. Elevated H3K18la enriches the Cop1 promoter, transcriptionally upregulating the E3 ubiquitin ligase COP1, which subsequently drives proteasomal degradation of GABAARβ2 and impairs ...
Yuan Meng   +8 more
wiley   +1 more source

Synapse

open access: yes, 2002
This is the Spring, 2002 edition of the ALHeLa newsletter - Synapse. Contents include: ALHeLA’s Annual Meeting ALHeLA Executive Committee Members (2002) ALHeLA Executive Board Meeting (April 5 ...
Libraries Association, Alabama Health
core  

PO64 | MANAGEMENT OF BLEEDING RISK IN PATIENTS WITH HEPATOCELLULAR CARCINOMA RECEIVING SYSTEMIC THERAPY: A SURVEY OF CLINICAL PRACTICE

open access: yesBleeding, Thrombosis and Vascular Biology
Background and Aims. Combination therapy of atezolizumab and bevacizumab is one of the proposed first-line treatment options for patients with advanced hepatocellular carcinoma (HCC). As vascular endothelial growth factor inhibitor, bevacizumab increases
Eline van Gansewinkel
doaj  

Home - About - Disclaimer - Privacy